RecruitingNot ApplicableNCT06563466

PEGASUS - Improving Treatment for Patients With Emotionally Unstable Personality Disorder

Sponsor

University Hospital Bispebjerg and Frederiksberg

Enrollment

100 participants

Start Date

Sep 1, 2024

Study Type

INTERVENTIONAL

Conditions

Borderline Personality Disorder Relatives

Summary

The purpose of the PEGASUS study is to conduct a pilot trial to test the feasibility and acceptability of the PEGASUS intervention, adding a case manager and family-based interventions meetings to the existing psychiatric integrated care-models known as "Treatment Packages" in Denmark. We will conduct a randomized, assessor-blinded parallel-groups superiority clinical trial, testing the PEGASUS intervention for emotionally unstable personality disorder "EUPD", borderline type (borderline personality disorder) compared to "Treatment as Usual" before moving on to testing in a full-scale trial. Participants will be assessed at baseline and 9 month post baseline at study conclusion

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying The experimental intervention PEGASUS and Treatment as usual for people with borderline personality disorder and relatives. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.